Business
AstraZeneca-Bristol Myers Squibb: The $400 Billion Megamerger Shaking the Global Pharma Industry
AstraZeneca is reportedly exploring a merger with Bristol Myers Squibb, potentially creating a pharmaceutical giant valued at nearly $400 billion. While the project remains exploratory, its scale is already shaking the global pharmaceutical industry.